Abstract
The goal of the present Project, whose Phase-1 will be completed in January 31st 2017 and whose partial Technical Report (first 6 months) has been already submitted to FAPESP, is the national synthesis and characterization of recombinant human bone morphogenetic protein-2 (rhBMP-2). During Phase-1, in agreement with the submitted proposal of technical viability, for the first time the per…